Published by ChinaMNC · Lianchi
Health Sector Signals for Foreign Founders: What the National Health Conference Means for China Operations
China's national health and wellness conference set priorities for the 15th Five-Year Plan period through 2035. Here is what foreign founders operating or registering companies in China should note about health-sector direction, without overreading it as regulation.
Foreign founders watching China's policy calendar often focus on industrial and trade signals. A national conference on health and wellness, held in Beijing on October 12–13, deserves attention too, because it sketches the direction of one of the country's largest service sectors for the period running to 2035. The meeting was addressed by Xi Jinping, who stressed that the 15th Five-Year Plan period is pivotal for reaching the goal of building a Healthy China by 2035. Premier Li Qiang delivered a concluding speech.
What the conference actually said
According to the official readout, Xi described public health as a marker of national strength and noted that since the 18th Party Congress the leadership has placed health protection in a priority strategic position. The readout states that China has built the world's largest systems for medical services, traditional medicine, disease prevention and control, and medical insurance. Those are claims from the source, not independent assessments.
The stated aim is a Healthy China that is balanced, inclusive, high-quality and efficient, with strong capabilities in health management, disease control, medical services, insurance support, pharmaceutical innovation and talent training. Xi also called for a health-first development strategy, with health considerations weighed in planning, policy design, project appraisal and construction.
Prevention, services and reform
The readout lists several priorities: prevention as the most economical and effective strategy; guiding the public toward sound health habits, including for young people; environmental and food-safety oversight; and a stronger disease control system aimed at preventing large-scale outbreaks. On services, it calls for strengthening primary care, optimizing the layout of medical institutions, promoting tiered diagnosis and treatment, chronic disease management, inheritance and innovation in traditional Chinese medicine with integrated Chinese-Western medicine, basic and original research, commercialization of research results, and growth of the health industry. It also mentions improving the patient experience.
On reform, the stated main direction is coordinated development and governance of medical services, medical insurance and pharmaceuticals. Specific items include implementing reform plans for public medical institutions, public-interest-oriented reform of public hospitals, stronger operating support for county and grassroots facilities, a multi-tier medical insurance system, optimized centralized procurement of drugs and consumables, medical insurance payment and fund-use policies, a sound drug supply and use mechanism, the national essential medicines system, and drug quality and safety supervision.
Why foreign founders should read this carefully
This is a directional political meeting, not a new law or a licensing rule. It does not by itself change market-access rules, registration procedures or tax treatment for foreign-invested enterprises. Founders should treat it as a signal of where public spending, institutional attention and regulatory emphasis are likely to concentrate during the 15th Five-Year Plan period, and confirm any concrete requirement with the competent authorities before acting.
- Health-adjacent businesses: Companies in medical devices, digital health, nutrition, fitness, food safety testing, elder care and related services may find the stated emphasis on prevention, primary care, chronic disease management and health-industry growth relevant to their medium-term planning.
- Pharmaceutical and TCM players: The readout highlights drug quality supervision, essential medicines, centralized procurement and innovation in traditional medicine. Pricing and procurement dynamics in these areas are worth monitoring.
- Insurance and payment: Multi-tier medical insurance and payment reform are named priorities. Founders whose products depend on reimbursement should track implementing rules rather than the conference text.
- Cross-border collaboration: Xi called for a global community of health for all, deeper Belt and Road health cooperation and innovation in foreign health assistance — relevant to founders exploring joint projects or partnerships.
Practical steps for founders
First, map your product or service against the stated priorities to see whether it sits in a favored direction or a more tightly supervised one. Second, keep your China entity's business scope and licenses aligned with what you actually do; health-related activities often carry sector-specific approvals. Third, build compliance around food, drug and medical-device rules where applicable, since supervision is explicitly emphasized. Fourth, monitor implementing documents from health, drug and insurance authorities, which translate conference language into operative rules. Fifth, for research or manufacturing partnerships, note the stated support for research translation and industry growth, while conducting your own due diligence.
Li Qiang's concluding remarks, as reported, stressed implementation: health-first orientation, the public-interest nature of basic medical services, balancing basic provision with quality, and reform, innovation and opening-up cooperation. He also listed priorities including major disease control, tiered diagnosis, patient experience, multi-tier insurance, traditional medicine, services for the elderly and children, and technology-enabled development.
For founders, the takeaway is modest but useful: China's health sector is being framed as a long-term national priority through 2035. That framing may shape policy support and regulatory attention, but it is not a substitute for checking specific market-entry, licensing and tax rules with professional advisers.
This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.